Jacobsen John R.'s Form 4 filing
DICE Therapeutics, Inc. (DICE) · filed Jun 2, 2023
- Accession no.
- 0001209191-23-034096
- Filed
- Jun 2, 2023
- Trade date
- Jun 1, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $572.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Jacobsen John R.CIK 0001880979 | Officer (CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 1, 2023 | Common Stock | SSaleDisposed | −14,307 | $30.31 | −$433,645.17 | 151,940 | Direct | |
| Jun 1, 2023 | Common Stock | SSaleDisposed | −4,443 | $31.24 | −$138,799.32 | 147,497 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.